BioMarCare is a portfolio company of Hadasit Bio-Holdings, a publicly traded holding company for businesses using intellectual property developed and owned by Israel's Hadassah University Hospital.
Israel-listed Micromedic has invested $1m in BioMarCare Technologies, with an option to invest an additional $1m in the local biotech company.
BioMarCare is a portfolio company of Hadasit Bio-Holdings, a publicly traded holding company for businesses using intellectual property developed and owned by Israel’s Hadassah University Hospital.
Ophir Shahaf, chief executive of Hadasit Bio-Holdings, said: "The investment validates the technology and research behind BioMarCare’s diagnostic kits.
"Not only will the agreement secure funds to advance the research and…